Search
Results: 10
Which Neuropsychological Tests? Predicting Cognitive Decline and Dementia in Parkinson's Disease in the ICICLE-PD Cohort.
Rachael A Lawson, Caroline H Williams-Gray, Marta Camacho, Gordon W Duncan, Tien K Khoo, David P Breen, Roger A Barker, Lynn Rochester, David J Burn, Alison J Yarnall, ICICLE-PD study group
May 28, 2021
BACKGROUND: Cognitive impairment is common in Parkinson's disease (PD), with 80% cumulatively developing dementia (PDD). OBJECTIVE: We sought to identify tests that are sensitive to change over time above normal ageing so as to...
The impact of neuroscience on society
Barbara J Sahakian, Annette B Bruhl, Jennifer Cook, Clare Killikelly, George Savulich, Thomas Piercy, Sepehr Hafizi, Jesus Perez, Emilio Fernandez-Egea, John Suckling, Peter B Jones
Jun 30, 2015
cognitive enhancers cognitive training game neuroethics Schizophrenia smart drugs Alzheimer Disease Attention Deficit Disorder with Hyperactivity Cognition Cognitive Behavioral Therapy Female Humans Male Neurocognitive Disorders Neurosciences Nootropic Agents Parkinson Disease Schizophrenia Video Games
European consensus for the diagnosis of MCI and mild dementia
Cristina Festari, Federico Massa, Matteo Cotta Ramusino, Federica Gandolfo, Valentina Nicolosi, Stefania Orini, Dag Aarsland, Federica Agosta, Claudio Babiloni, Mercè Boada, Barbara Borroni, Stefano Cappa, Bruno Dubois, Kristian S Frederiksen, Lutz Froelich, Valentina Garibotto, Jean Georges, Alexander Haliassos, Oskar Hansson, Frank Jessen, Anita Kamondi, Roy PC Kessels, Silvia Morbelli, John T O'Brien, Markus Otto, Armand Perret-Liaudet, Francesca B Pizzini, Craig W Ritchie, Philip Scheltens, Mathieu Vandenbulcke, Ritva Vanninen, Frans Verhey, Meike W Vernooij, Tarek Yousry, Wiesje M van der Flier, Flavio Nobili, Giovanni B Frisoni
Oct 10, 2022
INTRODUCTION: Etiological diagnosis of neurocognitive disorders of middle-old age relies on biomarkers, although evidence for their rational use is incomplete. A European task force is defining a diagnostic workflow where expert...
Anticancer chemotherapy in teenagers and young adults
Adaptation Psychological Adolescent Adult Antineoplastic Agents Cardiovascular Diseases fatigue Fertility Preservation Humans Infertility Interpersonal Relations Long-Term Care Neoplasms Neoplasms Second Primary Neurocognitive Disorders Patient Participation Precision Medicine Prognosis Risk Factors Social Skills Survivors Young Adult
Targeting the Unfolded Protein Response as a Disease-Modifying Pathway in Dementia.
Emad Sidhom, John T O'Brien, Adrian J Butcher, Heather L Smith, Giovanna R Mallucci, Benjamin R Underwood
Mar 29, 2022
Postnatal growth in preterm infants and later health outcomes
Ken K Ong, Kathy Kennedy, Eurídice Castañeda-Gutiérrez, Stewart Forsyth, Keith M Godfrey, Berthold Koletzko, Marie E Latulippe, Susan E Ozanne, Ricardo Rueda, Marieke H Schoemaker, Eline M van der Beek, Stef van Buuren, Mary Fewtrell
Aug 09, 2017
Postnatal growth in preterm infants and later health outcomes
Kenneth Ong, Kathy Kennedy, Eurídice Castañeda-Gutiérrez, Stewart Forsyth, Keith M Godfrey, Berthold Koletzko, Marie E Latulippe, Susan Ozanne, Ricardo Rueda, Marieke H Schoemaker, Eline M van der Beek, Stef van Buuren, Mary Fewtrell
Nov 04, 2015
In preterm infants, poor postnatal growth is associated with adverse neurocognitive outcomes; conversely, rapid postnatal growth is supposedly harmful for future development of metabolic diseases. CONCLUSION: In this systematic...
Neurocognitive reorganization between crystallized intelligence, fluid intelligence and white matter microstructure in two age-heterogeneous developmental cohorts.
Ivan L Simpson-Kent, Delia Fuhrmann, Joe Bathelt, Jascha Achterberg, Gesa Sophia Borgeest, Rogier A Kievit, CALM team
Feb 24, 2020
Despite the reliability of intelligence measures in predicting important life outcomes such as educational achievement and mortality, the exact configuration and neural correlates of cognitive abilities remain poorly understood...
Targeting the Unfolded Protein Response as a Disease-Modifying Pathway in Dementia
Dementia is a global medical and societal challenge; it has devastating personal, social and economic costs, which will increase rapidly as the world’s population ages. Despite this, there are no disease-modifying...
Emad Sidhom, John T O’Brien, Adrian J Butcher, Heather L Smith, Giovanna R Mallucci, Benjamin R Underwood
Feb 13, 2022